Clinical Trial

Subclinical Myocardial Dysfunction in Children With Wilson's Disease

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Wilson's disease (WD) is one of the most common metabolic liver diseases in older children. The most frequent clinical presentation is liver disease. However, Wilson's disease (WD) is a multisystem disorder. It is concluded that four modes of cardiac manifestations in Wilson's disease (WD) include arrhythmias, cardiomyopathy, cardiac death, and autonomic dysfunction. Such possible cardiac involvement should be added to the clinical picture of Wilson's disease (WD) involving the hepatic and central nervous system(CNS). The data on cardiac manifestations in children is very limited and only few adult studies are available. In this study, the investigators aim to unveil subclinical cardiac dysfunction in children with Wilson's disease with apparently normal cardiac functions by conventional assessment.
Trial Details
NCT Number NCT07765472
Lead Sponsor Hebatullah Fawzy
Conditions Wilson's Disease, Myocardial Dysfunction, Children, Wilson Disease, Speckle Tracking Echocardiography, Electrocardiographic Changes
Enrollment 72 participants
Start Date 2025-10-01
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14